In Brief: Drug advertising reviewers
Drug advertising reviewers: Lesley Frank, PhD, and Joan Hankin joined FDA in February. Frank, who is a medicinal chemist and former FDAer, was recruited from the Washington, D.C. law firm Arnold & Porter where she was associate counsel. Frank will report to DDMAC director Lucy Rose. Hankin, an associate counsel at King & Spaulding, will work in the Marketing Surveillance & Enforcement Branch I reporting to Norm Drezin...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth